Enter to open, tab to navigate, enter to select
Akorn, Inc. acquisition of certain assets of Sunovion Pharmaceuticals Inc.
| September 30, 2014 • Private Acquisition Agreements • $45 million (subject to purchase price adjustment). |
End of Document
© 2024 Thomson Reuters. No claim to original U.S. Government Works.